TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15056118

Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer cement
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Compomer (polyacid-modified composite resin)
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Restorations with cavity conditioners
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Restorations without cavity conditioners
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Adjacent unfilled surfaces
Number of subjects: 971

Group type: COMPARATOR
Intervention: Overall study results
Number of subjects: 971
Study: 11546903

Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen (50 microgram)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Continuous intrathecal baclofen infusion (up to 12 months)
Number of subjects: 21
Study: 9750976

Group type: EXPERIMENTAL
Intervention: Panic disorder on day 1
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Panic disorder on day 2
Number of subjects: 34

Group type: COMPARATOR
Intervention: Social phobia
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 34
Study: 7810826

Group type: EXPERIMENTAL
Intervention: 1% niclosamide lotion applied twice a week
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 350
Study: 3415883

Group type: COMPARATOR
Intervention: 0.5% amethocaine with 0% dextrose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% amethocaine with 1.25% dextrose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% amethocaine with 2.5% dextrose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% amethocaine with 5% dextrose
Number of subjects: 0
Study: 31829100

Group type: EXPERIMENTAL
Intervention: Enriched marine oil supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30813412

Group type: COMPARATOR
Intervention: Duodenal placebo and ileal placebo (DPIP)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Duodenal tastants and ileal placebo (DTIP)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Duodenal placebo and ileal tastants (DPIT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Duodenal tastants and ileal tastants (DTIT)
Number of subjects: 14
Study: 28941607

Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BiV)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Left ventricular pacing (LV)
Number of subjects: 120
Study: 25467040

Group type: EXPERIMENTAL
Intervention: Balloon uterine stent
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no balloon uterine stent)
Number of subjects: 60
Study: 23887151

Group type: COMPARATOR
Intervention: NMDA receptor blocker ketamine during retention sleep
Number of subjects: 0

Group type: COMPARATOR
Intervention: AMPA receptor blocker caroverine during retention sleep
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NMDA receptor coagonist D-cycloserine (DCS) during retention sleep
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DCS during a wake interval
Number of subjects: 0
Study: 21208675

Group type: EXPERIMENTAL
Intervention: Low-glycemic load (GL) diet
Number of subjects: 79

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 79
Study: 19204565

Group type: EXPERIMENTAL
Intervention: Active stretching techniques
Number of subjects: 100

Group type: COMPARATOR
Intervention: Straight leg raise (SLR) passive stretch
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PNF in the 90/90 active stretch
Number of subjects: 100
Study: 17086502

Group type: EXPERIMENTAL
Intervention: Commercially available ergonomic keyboard
Number of subjects: 68

Group type: COMPARATOR
Intervention: Modified version of the ergonomic keyboard designed to reduce activation force, vibration, and key travel
Number of subjects: 68
Study: 14977793

Group type: EXPERIMENTAL
Intervention: Clonidine 4 microg kg(‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam 0.4 mg kg(‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 11695354

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 220

Group type: COMPARATOR
Intervention: Nizatidine 150 mg b.i.d.
Number of subjects: 220
Study: 9159698

Group type: EXPERIMENTAL
Intervention: Medical interpreters translated hepatitis B as rauk tlaam, literally 'liver disease'
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Knowledge of illnesses named after symptom complexes that include symptoms of acute and chronic hepatitis
Number of subjects: 34
Study: 8203789

Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (D500)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 100
Study: 3580312

Group type: EXPERIMENTAL
Intervention: Anti-smoking health education during pregnancy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no anti-smoking health education)
Number of subjects: 0
Study: 29614877

Group type: EXPERIMENTAL
Intervention: Video-game group intervention
Number of subjects: 8
Study: 27797279

Group type: EXPERIMENTAL
Intervention: Reference brand enteric‐coated capsules
Number of subjects: 24

Group type: COMPARATOR
Intervention: Test generic enteric‐coated tablets
Number of subjects: 24
Study: 26571421

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (hyperuricemic)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (normouricemic)
Number of subjects: 73
Study: 23416142

Group type: EXPERIMENTAL
Intervention: α‐lipoic acid (LA) supplementation (600 mg/day) for 28 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (normal G6PD levels)
Number of subjects: 16
Study: 21321256

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Usual cardiac care
Number of subjects: 193
Study: 17934162

Group type: COMPARATOR
Intervention: 0.4 mg ITM alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 10 microg ITS plus 0.4 mg ITM
Number of subjects: 80
Study: 15105028

Group type: EXPERIMENTAL
Intervention: Supplement containing whey protein, amino acids, creatine, and carbohydrate
Number of subjects: 41

Group type: COMPARATOR
Intervention: Carbohydrate-only control drink
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Supplement
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control
Number of subjects: 41
Study: 11665963

Group type: EXPERIMENTAL
Intervention: Minocycline, 100 mg twice per day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydroxychloroquine, 200 mg twice per day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydroxychloroquine
Number of subjects: 60
Study: 9440749

Group type: EXPERIMENTAL
Intervention: IVMTX 1,000 mg/m2 plus IVMP 1,000 mg/m2 (regimen A)
Number of subjects: 709

Group type: COMPARATOR
Intervention: LDMTX 30 mg/m2 every 6 hours for six doses with IVMP 1,000 mg/m2 (regimen B)
Number of subjects: 709
Study: 8089345

Group type: EXPERIMENTAL
Intervention: Oral midazolam at a dose of 0.5 mg/kg with 25 mg hydroxyzine pamoate suspension as a vehicle
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nasal midazolam at a dose of 0.2 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both oral and nasal midazolam
Number of subjects: 100
Study: 2818919

Group type: EXPERIMENTAL
Intervention: Propofol 2.25 mg kg‐1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Thiopentone 4.8 mg kg‐1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Propofol 1.8 mg kg‐1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Thiopentone 4.7 mg kg‐1
Number of subjects: 48
Study: 31754133

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CTD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: β-blockers (metoprolol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: β-blockers (atenolol)
Number of subjects: 0
Study: 28193104

Group type: EXPERIMENTAL
Intervention: Multidisciplinary training on spiritual care (SC) for nurses
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Multidisciplinary training on spiritual care (SC) for physicians
Number of subjects: 255
Study: 27686138

Group type: EXPERIMENTAL
Intervention: Simulated Patients (SP) training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Seminar training
Number of subjects: 24
Study: 25145487

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1,200 mg/day)
Number of subjects: 930
Study: 22309819

Group type: EXPERIMENTAL
Intervention: Power of Two Online (self‐paced, Internet‐based marriage and relationship skills education program)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo-control group
Number of subjects: 79
Study: 20447955

Group type: EXPERIMENTAL
Intervention: Hyaluronan (sodium hyaluronate; Hyalgan) - 5 intra-articular injections weekly for 5 weeks
Number of subjects: 337

Group type: COMPARATOR
Intervention: Saline (placebo) - 5 intra-articular injections weekly for 5 weeks
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Hyaluronan
Number of subjects: 337

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Hyaluronan and Saline
Number of subjects: 337
Study: 17925486

Group type: EXPERIMENTAL
Intervention: sBAFF
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: anti-dsDNA antibody
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: sIL-2Ralpha
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: sCD13
Number of subjects: 52

Group type: COMPARATOR
Intervention: biomarkers
Number of subjects: 52
Study: 16213933

Group type: EXPERIMENTAL
Intervention: Ultrasonic scalpel tonsillectomy (US)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Blunt dissection tonsillectomy (BD)
Number of subjects: 122
Study: 12834513

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg/d or more)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Donepezil (effective dose for at least 9 to 12 months)
Number of subjects: 671
Study: 11763941

Group type: EXPERIMENTAL
Intervention: Oral-B CrossAction toothbrush
Number of subjects: 200

Group type: COMPARATOR
Intervention: Dr. Best InterDent toothbrush
Number of subjects: 200

Group type: COMPARATOR
Intervention: Crest DeepSweep toothbrush
Number of subjects: 200
Study: 8857384

Group type: EXPERIMENTAL
Intervention: Outlet policies and practices that may reduce the likelihood of sales to youth
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Outlet characteristics, policies and practices
Number of subjects: 15
Study: 1644325

Group type: EXPERIMENTAL
Intervention: Predigested nitrogen source (medium chain peptides)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Whole protein nitrogen source
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Subgroup with small bowel disease
Number of subjects: 12
Study: 6677083

Group type: EXPERIMENTAL
Intervention: Social consequences information (videotaped message)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control information (videotaped message)
Number of subjects: 54
Study: 31403816

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive-behavioral therapy for CSOs
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 100
Study: 30117129

Group type: EXPERIMENTAL
Intervention: Eldecalcitol 0.5 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Eldecalcitol 0.75 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Eldecalcitol (both doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Eldecalcitol
Number of subjects: 24
Study: 26747682

Group type: EXPERIMENTAL
Intervention: Standardized, evidence-based smoking cessation intervention
Number of subjects: 15

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 15
Study: 24473248

Group type: EXPERIMENTAL
Intervention: VRT and tDCS
Number of subjects: 20

Group type: COMPARATOR
Intervention: VRT and sham tDCS
Number of subjects: 20
Study: 21120580

Group type: EXPERIMENTAL
Intervention: FOLFOX4 (bevacizumab 5 mg/kg every 2 weeks, FOLFOX4 every 2 weeks)
Number of subjects: 84

Group type: COMPARATOR
Intervention: FFG (bevacizumab 5 mg/kg every 2 weeks, FFG weekly for 6 weeks of an 8-week cycle)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: FOLFOX4
Number of subjects: 84

Group type: COMPARATOR
Intervention: FFG
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: FOLFOX4 and FFG
Number of subjects: 84
Study: 19913311

Group type: EXPERIMENTAL
Intervention: Korean red ginseng 1 g
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (hop extract 0.25 g, caramel color 0.05 g, and red ginseng flavor 0.03 g)
Number of subjects: 25
Study: 16942792

Group type: EXPERIMENTAL
Intervention: Prenatal ultrasound
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomised controlled trials and observational studies
Number of subjects: 0
Study: 15788528

Group type: EXPERIMENTAL
Intervention: School-based physical activity program
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 198
Study: 11937315

Group type: EXPERIMENTAL
Intervention: Rubitecan 1.5 mg/m2 after overnight fasting
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Rubitecan 1.5 mg/m2 after a high calorie breakfast
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Rubitecan 1.5 mg/m2/day under fasting conditions for 5 consecutive days per week until disease progression
Number of subjects: 19
Study: 10432133

Group type: EXPERIMENTAL
Intervention: Soy supplementation (60 g of soy powder daily for 3 months)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 7487440

Group type: EXPERIMENTAL
Intervention: Bed rest
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Back school
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Case management
Number of subjects: 10
Study: 1835587

Group type: EXPERIMENTAL
Intervention: Chemotherapy with buserelin (CAF regimen)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Chemotherapy with buserelin (CMF regimen)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Chemotherapy with buserelin
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Depot buserelin
Number of subjects: 147

Group type: COMPARATOR
Intervention: CMF alone
Number of subjects: 147
Study: 6123719

Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 16082

Group type: COMPARATOR
Intervention: Control (Tetracycline ophthalmic ointment)
Number of subjects: 16082
Study: 31389614

Group type: EXPERIMENTAL
Intervention: Lidocaine with adrenaline (5 μg.ml-1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lidocaine without adrenaline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12
Study: 30570938

Group type: EXPERIMENTAL
Intervention: MRI within two weeks after trauma
Number of subjects: 356

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Point-of-care CRP-test for acute cough
Number of subjects: 356
Study: 27090108

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (1000 mg/day)
Number of subjects: 15
Study: 23461355

Group type: EXPERIMENTAL
Intervention: iCare Condition (ICC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Education/Information‐Only Condition (EOC)
Number of subjects: 150
Study: 21231862

Group type: EXPERIMENTAL
Intervention: 2 × 5/30 mg oxycodone HCl/niacin tablets
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: 2 × 7.5/30 mg oxycodone HCl/niacin tablets
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405
Study: 17522920

Group type: EXPERIMENTAL
Intervention: Focused endoscopic parathyroidectomy (MIVAP technique) plus quick intraoperative parathormone assay (qPTHa)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Endoscopic parathyroidectomy plus bilateral exploration
Number of subjects: 40
Study: 16503695

Group type: EXPERIMENTAL
Intervention: Moderate-intensity group (MIG; n = 9)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low-intensity group (LIG; n = 12)
Number of subjects: 29

Group type: COMPARATOR
Intervention: High-intensity group (HIG; n = 8)
Number of subjects: 29
Study: 12948274

Group type: EXPERIMENTAL
Intervention: Enteric-coated Thai garlic extract tablet (1.12% allicin or 5.6 mg/tablet) once daily for 12 weeks
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 11006807

Group type: EXPERIMENTAL
Intervention: Hands-on learning (making a model of a volcano)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Demonstration teaching method (observing the making of a model of a volcano)
Number of subjects: 73
Study: 9171769

Group type: EXPERIMENTAL
Intervention: Surgery alone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Late presentation to the family doctor
Number of subjects: 100
Study: 1543812

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole in the morning
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole in the evening
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3457137

Group type: EXPERIMENTAL
Intervention: Prophy-Jet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Rubber cup and paste techniques
Number of subjects: 21
Study: 30063589

Group type: COMPARATOR
Intervention: Immobilization protocol (postoperative forearm-based thumb-spica splint for 7 days, forearm-based thumb-spica cast for 5 weeks, custom forearm-based thermoplastic thumb-spica splint for 6 weeks)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Early mobilization protocol (postoperative forearm-based thumb-spica splint for 7 days, forearm-based thermoplastic thumb-spica splint for 3 weeks, hand-based thumb-spica splint for 4 weeks)
Number of subjects: 223
Study: 27780567

Group type: EXPERIMENTAL
Intervention: Experimental ONS (EONS, 20 g protein; 499 IU vitamin D3; 1.5 g CaHMB)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control ONS (CONS, 14 g protein; 147 IU vitamin D3)
Number of subjects: 330
Study: 24649963

Group type: EXPERIMENTAL
Intervention: Trainees' self-assessments of their communication skills in religious/spiritual communication
Number of subjects: 541

Group type: COMPARATOR
Intervention: Patients' reports of the occurrence of religious/spiritual communication
Number of subjects: 541
Study: 20483060

Group type: EXPERIMENTAL
Intervention: MET + CBT
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: MET
Number of subjects: 344

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study: 17855489

Group type: EXPERIMENTAL
Intervention: Uncircumcised men
Number of subjects: 2771

Group type: EXPERIMENTAL
Intervention: Increasing age
Number of subjects: 2771

Group type: EXPERIMENTAL
Intervention: Being married or having a live-in female partner
Number of subjects: 2771

Group type: EXPERIMENTAL
Intervention: Preferring 'dry' sex
Number of subjects: 2771

Group type: EXPERIMENTAL
Intervention: Reported penile cuts or abrasions during sex
Number of subjects: 2771

Group type: EXPERIMENTAL
Intervention: Increasing lifetime sexual partners
Number of subjects: 2771

Group type: EXPERIMENTAL
Intervention: Non-student occupation
Number of subjects: 2771

Group type: EXPERIMENTAL
Intervention: Reported condom use at last sex
Number of subjects: 2771
Study: 18675744

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg intravenous)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (isotonic NaCl solution)
Number of subjects: 71
Study: 15500496

Group type: EXPERIMENTAL
Intervention: Controlled ventilation with muscle relaxants and inhalation anesthesia
Number of subjects: 36

Group type: COMPARATOR
Intervention: Spontaneous ventilation with halothane in 100% oxygen
Number of subjects: 36
Study: 11207493

Group type: EXPERIMENTAL
Intervention: Cervical brush and Ayre's wooden spatula
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Acellon Combi
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Cervical brush
Number of subjects: 1000
Study: 9006420

Group type: EXPERIMENTAL
Intervention: Standardized macular hole surgery
Number of subjects: 120
Study: 8410120

Group type: EXPERIMENTAL
Intervention: Presence of tumor necrosis (TN)
Number of subjects: 728
Study: 3317346

Group type: EXPERIMENTAL
Intervention: Yeast-derived hepatitis B vaccine (10, 20, 40 micrograms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma-derived hepatitis B vaccine (20 micrograms)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (including both yeast-derived and plasma-derived vaccines)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revaccination of subjects with no detectable anti-HBs
Number of subjects: 0
Study: 30786916

Group type: EXPERIMENTAL
Intervention: Induction carbon ion radiotherapy (CIRT) boost followed by 60 GyE of proton irradiation with concurrent temozolomide (TMZ) at 75 mg/m2.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CIRT boost (dose determined in Phase I of this trial) followed by 60 GyE of proton irradiation with concurrent TMZ.
Number of subjects: 0

Group type: COMPARATOR
Intervention: 60 GyE (2 GyE per fraction) of proton irradiation with concurrent TMZ (control arm).
Number of subjects: 0
Study: 29916264

Group type: EXPERIMENTAL
Intervention: Energy Dispersive X-ray Fluorescence (EDXRF) spectrometry
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Empirical calibration approach using EDXRF
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Theoretical calibration approach using EDXRF
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Corrected EDXRF values using fixed bias subtraction and proportional bias correction
Number of subjects: 59
Study: 27272673

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) solution at 24 ml·kg·h
Number of subjects: 36

Group type: COMPARATOR
Intervention: Acetated Ringer's solution at 24 ml·kg·h
Number of subjects: 36

Group type: COMPARATOR
Intervention: Acetated Ringer's solution at 2 ml·kg·h
Number of subjects: 36
Study: 24565384

Group type: EXPERIMENTAL
Intervention: Midazolam 0.025 mg kg(‐1) intravenously
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 0
Study: 21558158

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Self‐help (CBS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waiting List Control (WLC)
Number of subjects: 45
Study: 21162928

Group type: EXPERIMENTAL
Intervention: Individualized vaginal surgery
Number of subjects: 150

Group type: COMPARATOR
Intervention: Kelly-Kennedy operation
Number of subjects: 150